West Pharmaceutical Services Inc. Bottom Line Rises In Q2

(RTTNews) - West Pharmaceutical Services Inc. (WST) revealed a profit for its second quarter that Increases, from last year

The company's bottom line totaled $154.0 million, or $2.15 per share. This compares with $131.8 million, or $1.82 per share, last year.

Excluding items, West Pharmaceutical Services Inc. reported adjusted earnings of $169.4 million or $2.37 per share for the period.

The company's revenue for the period rose 13.8% to $872.3 million from $766.5 million last year.

West Pharmaceutical Services Inc. earnings at a glance (GAAP) :

-Earnings: $154.0 Mln. vs. $131.8 Mln. last year. -EPS: $2.15 vs. $1.82 last year. -Revenue: $872.3 Mln vs. $766.5 Mln last year.

-Guidance: Next quarter EPS guidance: 2.14 To 2.24 Next quarter revenue guidance: 820 M To 835 M Full year EPS guidance: 8.85 To 9.05 Full year revenue guidance: 3.345 B To 3.380 B

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This data feed is not available at this time.